Edition:
United States

MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

15.52USD
18 Aug 2017
Change (% chg)

$-0.31 (-1.96%)
Prev Close
$15.83
Open
$15.67
Day's High
$15.75
Day's Low
$15.48
Volume
123,429
Avg. Vol
92,766
52-wk High
$32.54
52-wk Low
$14.36

MGNX.OQ

Chart for MGNX.OQ

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology... (more)

Overall

Beta: 2.83
Market Cap(Mil.): $582.52
Shares Outstanding(Mil.): 36.80
Dividend: --
Yield (%): --

Financials

  MGNX.OQ Industry Sector
P/E (TTM): -- 79.67 32.70
EPS (TTM): -4.18 -- --
ROI: -49.45 2.87 14.88
ROE: -52.35 5.20 16.12

BRIEF-MacroGenics Q2 net loss per share $1.14

* MacroGenics provides update on corporate progress and second quarter 2017 financial results

Aug 02 2017

BRIEF-Boxer Capital reports 5.5 pct passive stake in Macrogenics

* Boxer Capital, Llc reports 5.5 percent passive stake in Macrogenics Inc as of may 31, 2017 -sec filing Source text - http://bit.ly/2sVCckL Further company coverage:

Jun 12 2017

BRIEF-Macrogenics provides update on corporate progress and Q1 2017 financial results

* Macrogenics provides update on corporate progress and 1st quarter 2017 financial results

May 03 2017

BRIEF-Macrogenics announces registered direct offering of common stock

* Macrogenics announces registered direct offering of common stock

Apr 27 2017

BRIEF-Macrogenics provides announces 2016 financial results

* Macrogenics provides update on corporate progress and 2016 financial results

Feb 28 2017

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF241.40 -2.80
Roche Holding Ltd. (RO.S) CHF244.50 -2.30
Amgen, Inc. (AMGN.OQ) $167.29 -0.52
Xencor Inc (XNCR.OQ) $19.94 -0.41

Earnings vs. Estimates